About

Our Science

Our Programs

Careers

Investors & Media

Stockholder Tools

Global - Contact

Investor Contact

 

Media Contact

 

News Releases

10/10/2018

Constellation Pharmaceuticals Enhances and Expands Phase 2 MANIFEST Study of CPI-0610 in Myelofibrosis

9/12/2018

Constellation Pharmaceuticals Congratulates Dr. David Allis and Dr. Michael Grunstein, Winners of the 2018 Lasker Award

9/4/2018

Constellation Pharmaceuticals Announces Appointments to Board of Directors

8/14/2018

Constellation Pharmaceuticals Announces Second-Quarter and Six-Month 2018 Financial Results

7/18/2018

Constellation Pharmaceuticals Announces Pricing of Initial Public Offering

4/9/2018

Constellation Pharmaceuticals Announces $100 Million Financing

3/16/2018

Constellation Pharmaceuticals to Present at the Oppenheimer 28th Annual Healthcare Conference

3/6/2018

Constellation Pharmaceuticals to Present at the 38th Annual Cowen and Company Health Care Conference

2/9/2018

Constellation Pharmaceuticals Announces Upcoming Presentations of Lead EZH2 and BET Clinical Programs

1/16/2018

Constellation Pharmaceuticals Announces Initiation of Phase 1b/2 Study of CPI-1205

1/3/2018

Constellation Pharmaceuticals to Present at 36th Annual JP Morgan Healthcare Conference